Spago Nanomedical AB Logo

Spago Nanomedical AB

SPAGO | ST

Overview

Corporate Details

ISIN(s):
SE0004899474 (+2 more)
LEI:
549300DNLTVJ4OGO5X40
Country:
Sweden
Address:
Scheelevägen 22, 223 63 Lund
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

Spago Nanomedical is a clinical-stage nanomedicine company developing products for improved diagnostics and treatment of life-threatening diseases. The company leverages a proprietary platform of polymeric materials to create precision medical solutions. Its development pipeline is led by two key projects: SpagoPix and Tumorad®. SpagoPix (candidate drug SN132D) is a contrast agent designed to enhance the precision of MRI in detecting tumors and abnormalities in organs like the breast, liver, and pancreas. Tumorad® (candidate drug SN201) is a targeted radionuclide therapy being developed for the treatment of various cancers, which has shown favorable tumor accumulation in preclinical studies. The company's focus is on improving patient outcomes through more precise and effective diagnostics and therapies.

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for Spago Nanomedical AB. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Spago Nanomedical AB filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Spago Nanomedical AB via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
OXFORD BIODYNAMICS PLC Logo
Develops precision blood tests using 3D genomics for cancer diagnosis and therapy guidance.
United Kingdom OBD
OXFORD CANNABINOID TECHNOLOGIES HOLDINGS PLC Logo
A biopharma firm that developed cannabinoid pain therapies, now in administration and ceased trading.
United Kingdom OCTHF
Oxurion NV Logo
Biopharmaceutical company providing Contract Research Organization (CRO) services to life sciences.
Belgium OXUR
PCI Biotech Holding Logo
Develops light-activated drug delivery for cancer, dermatology, and gene therapy manufacturing.
Norway PCIB
Pentixapharm Holding AG Logo
Develops first-in-class radiopharmaceuticals for cancer diagnosis and therapy (theranostics).
Germany PTP
PharmaLundensis AB Logo
Develops drugs to bind and excrete heavy metals for treating COPD, bronchitis, and depression.
Sweden PHAL
Pharnext Logo France ALPHA
Pherecydes Pharma Logo
Developing precision phage therapies for antibiotic-resistant bacterial infections.
France ALPHE
Philogen Logo
Develops antibody-based biopharmaceuticals for targeted cancer and inflammation treatment.
Italy PHIL
PHYSIOMICS PLC Logo
De-risks oncology drug development for pharma/biotech using modeling and simulation.
United Kingdom PYC